StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Osho Krishan, Angel One

BUYGlenmark Pharmaceuticals

byOsho Krishan, Angel OneHorizon: NA (inferred Swing (≤2wk))7 Jul 2026via NDTV Profit (Live)

Entry₹2,270.9Stated
Target₹2,350
Total upside +3.48% (call closed)
Stop loss₹2,200-3.12% risk
At expiry₹2,239.620 Jul 2026, 3:30 pm
Expired-1.38%
Follow Osho Krishan for new calls(25% target hit, 104 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 129 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 20 Jul 2026
3 supporting0 opposing
Supports the BUY call (3)

Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial.

NSE · Press Release·6 Jul · 2w ago

(opens in new tab)

Glenmark Pharmaceuticals Ltd is advancing its Multi-Country Phase 3 Clinical Trial of Trastuzmab rezetecan in Platinum-Resistant Ovarian Cancer.

BSE · Company Update·2 Jul · 3w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·29 Jun · 3w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.